-
1Academic Journal
المؤلفون: A. A. Androsov, L. L. Chuvalov, M. S. Taratkin, D. O. Korolev, Yu. P. Gorobets, L. M. Rapoport, D. V. Enikeev, D. G. Tsarichenko, M. E. Enikeev
المصدر: Вестник урологии, Vol 11, Iss 3, Pp 87-97 (2023)
مصطلحات موضوعية: erectile dysfunction, physical therapy modalities, radiowave therapy, low-intensity extracorporeal shock wave therapy, Diseases of the genitourinary system. Urology, RC870-923
وصف الملف: electronic resource
-
2Academic Journal
المؤلفون: A. E. Alfimov, D. Yu. Alexeeva, D. O. Korolev, D. M. Gorinova, M. E. Enikeev, L. M. Rapoport, А. Е. Алфимов, Д. Ю. Алексеева, Д. О. Королев, Д. М. Горинова, М. Э. Еникеев, Л. М. Рапопорт
المصدر: Andrology and Genital Surgery; Том 25, № 1 (2024); 24-30 ; Андрология и генитальная хирургия; Том 25, № 1 (2024); 24-30 ; 2412-8902 ; 2070-9781
مصطلحات موضوعية: маркер литогенной активности, идиопатический кальциевый нефролитиаз, метафилактика, активность литогенного процесса
وصف الملف: application/pdf
Relation: https://agx.abvpress.ru/jour/article/view/732/563; Rule AD, Lieske JC, Li X, et al. The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol. 2014;25(12):2878-2886. PMID: 25104803. doi:10.1681/ ASN.2013091011.; Laube N, Pullmann M. The use of risk indices: do they predict recurrence? Yes, they (at least some) do. Urol Res. 2006 Apr;34(2):118-21. PMID: 16397777. doi:10.1007/s00240-005-0022-4.; D’Costa MR, Pais VM, Rule AD. Leave no stone unturned: defining recurrence in kidney stone formers. Curr Opin Nephrol Hypertens. 2019 Mar;28(2):148-153. PMID: 30531469. doi:10.1097/MNH.0000000000000478.; Daudon M, Hennequin C, Boujelben G, et al. Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int. 2005 May;67(5):1934-43. PMID: 15840041. doi:10.1111/j.1523-1755.2005.00292.x.; Gambaro G, Croppi E, Coe F, et al. Consensus Conference Group. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016 Dec;29(6):715-734. PMID: 27456839. doi:10.1007/s40620-016-0329-y.; Williams JC Jr, Gambaro G, Rodgers A, et al. Urine and stone analysis for the investigation of the renal stone former: a consensus conference. Urolithiasis. 2021 Feb;49(1):1-16. PMID: 33048172. doi:10.1007/s00240-020-01217-3.; Williams JC, Al-Awadi H, Muthenini M, et al. Stone morphology distinguishes two pathways of idiopathic calcium oxalate stone pathogenesis. J Endourol. 2021 Dec 17. PMID: 34915736. doi:10.1089/end.2021.0685.; Estrade V, Denis de Senneville B, Meria P, et al. Toward improved endoscopic examination of urinary stones: a concordance study between endoscopic digital pictures vs microscopy. BJU Int. 2021 Sep;128(3):319-330. PMID: 33263948. doi:10.1111/bju.15312.; D’Costa MR, Haley WE, Mara KC, et al. Symptomatic and Radiographic Manifestations of Kidney Stone Recurrence and Their Prediction by Risk Factors: A Prospective Cohort Study. J Am Soc Nephrol. 2019 Jul;30(7):1251-1260. PMID: 31175141. doi:10.1681/ASN.2018121241.; Sutherland. J. W., Parks, J. H. and Coe, F. L.: Recurrence after a single renal stone in a community practice. Miner. Electrolyte Metab., 11: 267, 1985. PMID: 4033604.; Johnson, C. M., Wilson, D. M., OFallon, W. M., et al. Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int., 16 624, 1979. PMID: 548606.doi:10.1038/ki.1979.173.; Ahlstrand, C. and Tiselius, H. G.: Recurrences during a 10-year follow-up after first renal stone episode. Urol. Res., 18: 397, 1990. PMID: 2100415. doi:10.1007/BF00297372.; Ljunghall. S., Danielson, B. G.: A prospective study of renal stone recurrences. Brit. J. Urol., 56: 122, 1984. PMID: 6498430 doi:10.1111/j.1464-410x.1984.tb05346.x; Методология дистанционного мониторинга пациентов с мочекаменной болезнью: разработка и первичная апробация / Г. С. Лебедев, И. А. Шадеркин, М. А. Газимиев и др // Урология. 2021;5:26– 34), PMID: 34743428.; Lindberg JS, Cole FE, Romani W, et al. Calcium Oxalate Stone Agglomeration Inhibition [tm] Reflects Renal Stone-Forming Activity. Ochsner J. 2000 Apr;2(2):68-78. PMID: 21811395.; Шустер П. И., Глыбочко П.В. Состояние процессов камнеобразования в почках на фоне андрогенной терапии, Саратовский научно-медицинский журнал, vol. 5, no. 4, 2009.; Grases F, García-Ferragut L, Costa-Bauzá A, et al. Simple test to evaluate the risk of urinary calcium stone formation. Clin Chim Acta. 1997 Jul 4;263(1):43-55. PMID: 9247727 . doi:10.1016/s0009-8981(97)06554-6.; Tiselius HG. Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate? Urolithiasis. 2015 Jan;43 Suppl 1:47-57. PMID: 25086904. doi:10.1007/s00240-014-0698-4.; Marickar YM, Salim A. Temporary risk identification in urolithiasis. Urol Res. 2009 Dec;37(6):377-80. PMID: 19830414. doi:10.1007/s00240-009-0225-1.; Rodriguez A, Cunha TDS, Rodgers AL, et al. Comparison of Supersaturation Outputs from Different Programs and Their Application in Testing Correspondence with Kidney Stone Composition. J Endourol. 2021 May;35(5):687-694. PMID: 33050741. doi:10.1089/end.2020.0894.; Marangella M, Petrarulo M, Vitale C, et al. LITHORISK.COM: the novel version of a software for calculating and visualizing the risk of renal stone. Urolithiasis. 2021 Jun;49(3):211-217. PMID: 33245396. doi:10.1007/s00240-020-01228-0.; Tiselius H-G (1997) Risk formulas in calcium oxalate urolithiasis. World J Urol 15:176. PMID: 9228725. doi:10.1007/BF02201855; Robertson WG. A risk factor model of stone-formation. Front Biosci. 2003 Sep 1;8:s1330-8. PMID: 12957848. doi:10.2741/1181.; Robertson WG. Methods for diagnosing the risk factors of stone formation. Arab J Urol. 2012 Sep;10(3):250-7. PMID: 26558033. doi:10.1016/j.aju.2012.03.006.; Ganter, K., Bongartz, D. & Hesse, A. Tamm-Horsfall protein excretion and its relation to citrate in urine of stone-forming patients. Urology 53, 492–495 (1999). PMID: 10096372 DOI:10.1016/s0090-4295(98)00581-0.; Wu J, Zhao J, Zhao Z, et al. Significance of TRPV5 and OPN biomarker levels in clinical diagnosis of patients with early urinary calculi. Am J Transl Res. 2021 Jun 15;13(6):6778-6783. PMID: 34306426.; Boonla C, Wunsuwan R, Tungsanga K, et al. Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res. 2007 Aug;35(4):185-91. PMID: 17541572. doi:10.1007/s00240-007-0098-0.; Tsujihata M, Tsujikawa K, Tei N, et al. Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers. Int J Urol. 2006 Mar;13(3):197-201. PMID: 16643608. doi:10.1111/j.1442-2042.2006.01271.x; Golovanov S.A., Sinyukhin V.N., Tashlitsky V.A., et al. Urinary excretion of tryptophan, lysine, trimethyllysine, sarcosine, choline and 4-pyridoxic acid in urolithiasis. Experimental and Clinical Urology 2022;15(1):68-75; Голованов С.А., Синюхин В.Н., Ташлицкий В.А., и др. Экскреция триптофана, лизина, триметиллизина, саркозина, холина и 4-пиридоксиновой кислоты с мочой при мочекаменной болезни. Экспериментальная и клиническая урология 2022;15(1):68-75; https://doi.org/10.29188/2222-8543-2022-15-1-68-75; Silverio AA, Chung WY, Cheng C, et al. The potential of at-home prediction of the formation of urolithiasis by simple multifrequency electrical conductivity of the urine and the comparison of its performance with urine ion-related indices, color and specific gravity. Urolithiasis. 2016 Apr;44(2):127-34. PMID: 22301017. doi:10.1007/s00240-015-0812-2.; Kavouras SA, Suh HG, Vallet M, et al. Urine osmolality predicts calcium-oxalate crystallization risk in patients with recurrent urolithiasis. Urolithiasis. 2021 Oct;49(5):399-405. PMID: 33635363. doi:10.1007/s00240-020-01242-2.; Shoag J, Eisner BH. Relationship between C-reactive protein and kidney stone prevalence. J Urol 2014;191:372-5. PMID: 24071479. doi:10.1016/j.juro.2013.09.033; Mao W, Wu J, Zhang Z, et al. Neutrophil-lymphocyte ratio acts as a novel diagnostic biomarker for kidney stone prevalence and number of stones passed. Transl Androl Urol. 2021 Jan;10(1):77- 86. PMID: 33532298. doi:10.21037/tau-20-890.; Kang HW, Seo SP, Kim WT, et al. Hypertriglyceridemia is associated with increased risk for stone recurrence in patients with urolithiasis. Urology. 2014 Oct;84(4):766-71. PMID: 25106943. doi:10.1016/j.urology.2014.06.013.; Sonmez MG, Kozanhan B, Deniz ÇD, et al. Dynamic thiol/ disulfide homeostasis as a novel indicator of oxidative stress in patients with urolithiasis. Investig Clin Urol. 2019 Jul;60(4):258- 266. PMID: 31294135. doi:10.4111/icu.2019.60.4.258.; Ciudin A, Luque MP, Salvador R, et al. Abdominal computed tomography--a new tool for predicting recurrent stone disease. J Endourol. 2013 Aug;27(8):965-9. PMID: 23668633. doi:10.1089/end.2013.0161.; Ciudin A, Luque MP, Salvador R, et al. The evolution of CT diagnosed papillae tip microcalcifications: can we predict the development of stones? J Endourol. 2014 Aug;28(8):1016-21. PMID: 24735416. doi:10.1089/end.2014.0151.; Ferraro PM, Vittori M, Macis G, et al. Changes in renal papillary density after hydration therapy in calcium stone formers. BMC Urol. 2018 Nov 12;18(1):101. PMID: 30419887. doi:10.1186/s12894-018-0415-7.; Borofsky MS, Paonessa JE, Evan AP, et al. A Proposed Grading System to Standardize the Description of Renal Papillary Appearance at the Time of Endoscopy in Patients with Nephrolithiasis. J Endourol. 2016 Jan;30(1):122-7. PMID: 26414908. doi:10.1089/end.2015.0298.; Almeras C, Pradere B, Estrade V, et al. On Behalf Of The Lithiasis Committee Of The French Urological Association. Endoscopic Papillary Abnormalities and Stone Recognition (EPSR) during Flexible Ureteroscopy: A Comprehensive Review. J Clin Med. 2021 Jun 29;10(13):2888. PMID: 34209668. doi:10.3390/jcm10132888.; Robertson WG, Peacock M, Marshall RW, et al. Saturationinhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. N Engl J Med. 1976;294(5):249- 252. PMID: 1244550. doi:10.1056/NEJM197601292940504.; Hallson PC, Rose GA. A new urinary test for stone «activity». Br J Urol. 1978 Dec;50(7):442-8. PMID: 753493. doi:10.1111/j.1464-410x.1978.tb06188.x.; Pak CY, Galosy RA. Propensity for spontaneous nucleation of calcium oxalate. Quantitative assessment by urinary FPR-APR discriminant score. Am J Med. 1980;69(5):681-689. PMID: 7435510. doi:10.1016/0002-9343(80)90418-0.; Nicar MJ, Hill K, Pak CY. A simple technique for assessing the propensity for crystallization of calcium oxalate and brushite in urine from the increment in oxalate or calcium necessary to elicit precipitation. Metabolism. 1983 Sep;32(9):906-10. PMID: 6888271.doi:10.1016/0026-0495(83)90205-6.; Tiselius HG. Measurement of the risk of calcium phosphate crystallization in urine. Urol Res. 1987;15(2):79-81. doi:10.1007/BF00260937. PMID: 3590433.; Erwin DT, Kok DJ, Alam J, et al. Calcium oxalate stone agglomeration reflects stone-forming activity: citrate inhibition depends on macromolecules larger than 30 kilodalton. Am J Kidney Dis. 1994 Dec;24(6):893-900. PMID: 7985666. doi:10.1016/s0272-6386(12)81057-2.; Grases F, García-Ferragut L, Costa-Bauzá A, et al. Simple test to evaluate the risk of urinary calcium stone formation. Clin Chim Acta. 1997 Jul 4;263(1):43-55. PMID: 9247727.ndoi: 10.1016/s0009-8981(97)06554-6.; Шатохина С.Н., Шабалин В.Н. Ранняя диагностика уролитиаза, определение степени его активности и состава камнеобразующих солей мочи (система Литос. Урология и нефрология. 1998. № 1. С. 19–23)).; Laube N, Berg W, Bernsmann F, et al. Induced urinary crystal formation as an analytical strategy for the prediction and monitoring of urolithiasis and other metabolism-related disorders. EPMA J. 2014 Aug 16;5(1):13. doi:10.1186/1878-5085-5-13. PMID: 25206937.; Yang, B. et al. Calcium oxalate crystallization index (COCI): an alternative method for distinguishing nephrolithiasis patients from healthy individuals. Ann. Clin. Lab. Sci. 44, 262–271 (2014). PMID: 25117095.; More-Krong P, Tubsaeng P, Madared N, et al. Clinical validation of urinary indole-reacted calcium oxalate crystallization index (iCOCI) test for diagnosing calcium oxalate urolithiasis. Sci Rep. 2020 May 20;10(1):8334. PMID: 32433482.doi:10.1038/s41598-020-65244-1.; Porowski T, Kirejczyk JK, Mrozek P, et al. Upper metastable limit osmolality of urine as a predictor of kidney stone formation in children. Urolithiasis. 2019 Apr;47(2):155-163. PMID: 29356875. doi:10.1007/s00240-018-1041-2.; https://agx.abvpress.ru/jour/article/view/732
-
3Academic Journal
المؤلفون: A. E. Alfimov, A. I. Shaderkina, D. O. Korolev, D. M. Gorinova, M. E. Enikeev, D. G. Tsarichemko, L. M. Rapoport
المصدر: Андрология и генитальная хирургия, Vol 23, Iss 4, Pp 36-45 (2023)
مصطلحات موضوعية: kidney stones, idiopathic calcium nephrolithiasis, metaphylaxis, activity of lithogenic process, marker of lithogenic activity, Surgery, RD1-811, Diseases of the genitourinary system. Urology, RC870-923
وصف الملف: electronic resource
-
4Academic Journal
المؤلفون: O. V. Snurnitsyna, A. N. Nikitin, M. V. Lobanov, Zh. Sh. Inoyatov, L. M. Rapoport, M. E. Enikeev
المصدر: Вестник урологии, Vol 10, Iss 1, Pp 60-69 (2022)
مصطلحات موضوعية: cystocele, hysteroptosis, anterior apical prolapse, mesh-surgery, pelvic organ prolapse, Diseases of the genitourinary system. Urology, RC870-923
وصف الملف: electronic resource
-
5Academic Journal
المؤلفون: A. V. Proskura, Yu. G. Alyaev, V. V. Borisov, D. V. Butnaru, L. M. Rapoport, E. S. Sirota, A. Yu. Suvorov, D. N. Fiev, E. V. Shpot, E. A. Bezrukov, M. E. Enikeev, G. N. Akopyan, D. O. Korolev, A. A. Vorobiev, M. M. Chernenkiy, I. M. Chernenkiy, Kh. M. Ismailov, Z. S. Shomukimova, А. В. Проскура, Ю. Г. Аляев, В. В. Борисов, Д. В. Бутнару, Л. М. Рапопорт, Е. С. Сирота, А. Ю. Суворов, Д. Н. Фиев, Е. В. Шпоть, Е. А. Безруков, М. Э. Еникеев, Г. Н. Акопян, Д. О. Королев, A. А. Воробьев, М. М. Черненький, И. М. Черненький, Х. М. Исмаилов, З. С. Шомукимова
المصدر: Andrology and Genital Surgery; Том 24, № 3 (2023); 66-74 ; Андрология и генитальная хирургия; Том 24, № 3 (2023); 66-74 ; 2412-8902 ; 2070-9781
مصطلحات موضوعية: клубочковая фильтрация, renal function, computed tomography, glomerular filtration, функция, компьютерная томография
وصف الملف: application/pdf
Relation: https://agx.abvpress.ru/jour/article/view/684/534; Campbell S.C., Novick A.C., Belldegrun A. et al. Guideline for management of the clinical T1 renal mass. J Urol 2009;182(4):1271–9. DOI:10.1016/j.juro.2009.07.004; Ljungberg B., Bensalah K., Canfield S. et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 2015;67(5):913–24. DOI:10.1016/j.eururo.2015.01.005; MacLennan S., Imamura M., Lapitan M.C. et al. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol 2012;62(6):1097–117. DOI:10.1016/j.eururo.2012.07.028; Liss M.A., Wang S., Palazzi K. et al. Evaluation of national trends in the utilization of partial nephrectomy in relation to the publication of the American Urologic Association guidelines for the management of clinical T1 renal masses. BMC Urol 2014;14:101. DOI:10.1186/1471-2490-14-101; Fergany A.F., Hafez K.S., Novick A.C. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 2000;163(2):442–5. PMID: 10647650.; Capitanio U., Terrone C., Antonelli A. et al. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a–T1b renal mass and normal preoperative renal function. Eur Urol 2015;67(4):683–9. DOI:10.1016/j.eururo.2014.09.027; MacLennan S., Imamura M., Lapitan M.C. et al. Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol 2012;61(5):972–93. DOI:10.1016/j.eururo.2012.02.039; Kim S.P., Thompson R.H., Boorjian S.A. et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol 2012;188(1):51–7. DOI:10.1016/j.juro.2012.03.006; Scosyrev E., Messing E.M., Sylvester R. et al. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol 2014;65(2):372–7. DOI:10.1016/j.eururo.2013.06.044; Kim C.S., Bae E.H., Ma S.K. et al. Impact of partial nephrectomy on kidney function in patients with renal cell carcinoma. BMC Nephrol 2014;15:181. DOI:10.1186/1471-2369-15-181; McCallum W., Testani J.M. Updates in cardiorenal syndrome. Med Clin North Am 2023;107(4):763–80. DOI:10.1016/j.mcna.2023.03.011; Van Poppel H., Da Pozzo L., Albrecht W. et al. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2007;51(6):1606–15. DOI:10.1016/j.eururo.2006.11.013; Antonelli A., Ficarra V., Bertini R. et al. Elective partial nephrectomy is equivalent to radical nephrectomy in patients with clinical T1 renal cell carcinoma: results of a retrospective, comparative, multi-institutional study. BJU Int 2012;109(7):1013–8. DOI:10.1111/j.1464-410X.2011.10431.x; Gong I.H., Hwang J., Choi D.K. et al. Relationship among total kidney volume, renal function and age. J Urol 2012;187(1):344–9. DOI:10.1016/j.juro.2011.09.005; Jeon H.G., Gong I.H., Hwang J.H. et al. Prognostic significance of preoperative kidney volume for predicting renal function in renal cell carcinoma patients receiving a radical or partial nephrectomy. BJU Int 2012;109(10):1468–73. DOI:10.1111/j.1464-410X.2011.10531.x; Tobert C.M., Boelkins B., Culver S. et al. Surgeon assessment of renal preservation with partial nephrectomy provides information comparable to measurement of volume preservation with 3D image analysis. J Urol 2014;191(5):1218–24. DOI:10.1016/j.juro.2013.11.003; Eum S.H., Lee H., Ko E.J. et al. Comparison of CT volumetry versus nuclear renography for predicting remaining kidney function after uninephrectomy in living kidney donors. Sci Rep 2022;12(1):5144. DOI:10.1038/s41598-022-09187-9; Hori Y., Obinata D., Funakoshi D. et al. Preoperative CT volumetry of estimated residual kidney for prediction of postoperative chronic kidney disease in patients with renal cell carcinoma. Clin Exp Nephrol 2021;25(3):315–21. DOI:10.1007/s10157-020-01984-8; Yanishi M., Kinoshita H., Yoshida T. et al. Comparison of renal scintigraphy and computed tomographic renal volumetry for determining split renal function and estimating post-transplant renal function. Transplant Proc 2015;47(9):2700–2. DOI:10.1016/j.transproceed.2015.07.037; Almeida M., Pereira P.R., Ramos M. et al. CT volumetry performs better than nuclear renography in predicting estimated renal function one year after living donation. Int Urol Nephrol 2023;55(3):553–62. DOI:10.1007/s11255-022-03441-9; You S., Ma X., Zhang C. et al. Determination of single-kidney glomerular filtration rate (GFR) with CT urography versus renal dynamic imaging Gates method. Eur Radiol 2018;28(3):1077–84. DOI:10.1007/s00330-017-5061-z; Diez A., Powelson J., Sundaram C.P. et al. Correlation between CT-based measured renal volumes and nuclear-renography-based split renal function in living kidney donors. Clinical diagnostic utility and practice patterns. Clin Transplant 2014;28(6):675–82. DOI:10.1111/ctr.12365; Nilsson H., Wadström J., Andersson L.G. et al. Measuring split renal function in renal donors: can computed tomography replace renography? Acta Radiol 2004;45(4):474–80. DOI:10.1080/02841850410005282; Tsushima Y., Blomley M.J., Okabe K. et al. Determination of glomerular filtration rate per unit renal volume using computerized tomography: correlation with conventional measures of total and divided renal function. J Urol 2001;165(2):382–5. DOI:10.1097/00005392-200102000-00007; Hackstein N., Buch T., Rau W.S. et al. Split renal function measured by triphasic helical CT. Eur J Radiol 2007;61(2):303–9. DOI:10.1016/j.ejrad.2006.09.001; Helck A., Schonermarck U., Habicht A. et al. Determination of split renal function using dynamic CT-angiography: preliminary results. PloS One 2014;9(3):e91774. DOI:10.1371/journal.pone.0091774; Summerlin A.L., Lockhart M.E., Strang A.M. et al. Determination of split renal function by 3D reconstruction of CT angiograms: a comparison with gamma camera renography. AJR Am J Roentgenol 2008;191(5):1552–8. DOI:10.2214/AJR.07.4023; Hua L., Sebben R., Olakkengil S. et al. Correlation between computed tomography volumetry and nuclear medicine split renal function in live kidney donation: a single-centre experience. ANZ J Surg 2020;90(7–8):1347–51. DOI:10.1111/ans.16087; Shi W., Liang X., Wu N. et al. Assessment of split renal function using a combination of contrast-enhanced CT and serum creatinine values for glomerular filtration rate estimation. AJR Am J Roentgenol 2020;215(1):142–7. DOI:10.2214/AJR.19.22125; Lal H., Yadav P., Kaul A. et al. Role of computed tomography in estimation of residual renal function at one year after donor nephrectomy: comparison with nuclear scintigraphy. Saudi J Kidney Dis Transpl 2021;32(4):993–8. DOI:10.4103/1319-2442.338312; Patankar K., Low R.S., Blakeway D., Ferrari P. Comparison of computer tomographic volumetry versus nuclear split renal function to determine residual renal function after living kidney donation. Acta Radiol 2014;55(6):753–60. DOI:10.1177/0284185113504195; Barbas A.S., Li Y., Zair M. et al. CT volumetry is superior to nuclear renography for prediction of residual kidney function in living donors. Clin Transplant 2016;30(9):1028–35. DOI:10.1111/ctr.12784; Mitsui Y., Sadahira T., Araki M. et al. The assessment of renal cortex and parenchymal volume using automated CT volumetry for predicting renal function after donor nephrectomy. Clin Exp Nephrol 2018;22(2):453–58. DOI:10.1007/s10157-017-1454-1; Houbois C., Haneder S., Merkt M. et al. Can computed tomography volumetry of the renal cortex replace MAG3-scintigraphy in all patients for determining split renal function? Eur J Radiol 2018;103:105–11. DOI:10.1016/j.ejrad.2018.04.016; Fiev D., Proskura A., Khokhlachev S. et al. A prospective study of novel mathematical analysis of the contrast-enhanced computed tomography vs renal scintigraphy in renal function evaluation. Eur J Radiol 2020;130:109169. DOI:10.1016/j.ejrad.2020.109169; Фиев Д.Н. Виртуальное моделирование для выбора метода лечения и планирования операций при хирургических заболеваниях почек. Дис. д-ра мед. наук. М., 2015.; Сирота Е.С. Компьютер-ассистированные операции при заболеваниях почки. Дис. . д-ра мед. наук. М., 2018.; Проскура А.В. Оценка функции почки с помощью трехмерной виртуальной обработки данных МСКТ с контрастированием. Дис. . канд. мед. наук. М., 2020.; Попов С.В., Гусейнов Р.Г., Борисенков М.Б. и др. Сравнительная оценка выживаемости пациентов с раком почки после эндовидеохирургической радикальной нефрэктомии и резекции почки. Онкоурология 2013;9(2):21–5. DOI:10.17650/1726-9776-2013-9-2-21-25; Ракул С.А., Поздняков К.В., Елоев Р.А. Отдаленные онкологические результаты хирургического лечения локализованных опухолей почек. Онкоурология 2021;17(4):27–37. DOI:10.17650/1726-9776-2021-17-4-27-37; Котов С.В., Неменов А.А., Юсуфов А.Г. и др. Сравнение периоперационных и ранних функциональных результатов лапароскопической резекции почки с опухолью при стадии cT1aN0M0 и cT1b–T2aN0M0. Онкоурология 2021;17(4):38–46. DOI:10.17650/1726-9776-2021-17-4-38-46; Волкова М.И., Скворцов И.Я., Климов А.В. и др. Влияние объема хирургического вмешательства на функциональные результаты и кардиоспецифическую выживаемость у больных клинически локализованным раком почки. Онкоурология 2014;10(3):22–30. DOI:10.17650/1726-9776-2014-10-3-22-30; Larcher A., Wallis C.J.D., Pavan N. et al. Outcomes of minimally invasive partial nephrectomy among very elderly patients: report from the RESURGE collaborative international database. Cent European J Urol 2020;73(3):273–9. DOI:10.5173/ceju.2020.0179; Porpiglia F., Fiori C., Bertolo R. et al. Long-term functional evaluation of the treated kidney in a prospective series of patients who underwent laparoscopic partial nephrectomy for small renal tumors. Eur Urol 2012;62(1):130–5. DOI:10.1016/j.eururo.2012.02.001; Pansadoro A., Cochetti G., D’amico F. et al. Retroperitoneal laparoscopic renal tumour enucleation with local hypotension on demand. World J Urol 2015;33(3):427–32. DOI:10.1007/s00345-014-1325-2; Rod X., Peyronnet B., Seisen T. et al. Impact of ischaemia time on renal function after partial nephrectomy: a systematic review. BJU Int 2016;118(5):692–705. DOI:10.1111/bju.13580; Jiang Y.L., Peng C.X., Wang H.Z., Qian LJ. Comparison of the long-term follow-up and perioperative outcomes of partial nephrectomy and radical nephrectomy for 4 cm to 7 cm renal cell carcinoma: a systematic review and meta-analysis. BMC Urol 2019;19(1):48. DOI:10.1186/s12894-019-0480-6; https://agx.abvpress.ru/jour/article/view/684
-
6Academic Journal
المؤلفون: I. A. Rezvikh, L. M. Rapoport, L. L. Chuvalov, E. S. Belisheva, A. A. Chibarov, N. B. Paramonova, E. E. Schelokova, Yu. S. Strakhov, M. A. Shariya, A. A. Vorobyev, I. V. Fokin, M. E. Enikeev
المصدر: Андрология и генитальная хирургия, Vol 22, Iss 2, Pp 35-44 (2021)
مصطلحات موضوعية: prostate cancer, multiparametric magnetic resonance imaging, robot-assisted radical prostatectomy, nerve-sparing prostatectomy, organ-sparing prostatectomy, Surgery, RD1-811, Diseases of the genitourinary system. Urology, RC870-923
وصف الملف: electronic resource
-
7Academic Journal
المؤلفون: O. V. Snurnitsyna, Zh. Sh. Inoyatov, M. V. Lobanov, O. Yu. Malinina, L. M. Rapoport, M. E. Enikeev
المصدر: Вестник урологии, Vol 9, Iss 1, Pp 72-79 (2021)
مصطلحات موضوعية: cystitis, dysuria, hypospadias, urethral hypermobility, urethra-hymenal adhesions, hyaluronic acid, filler, Diseases of the genitourinary system. Urology, RC870-923
وصف الملف: electronic resource
-
8Academic Journal
المؤلفون: J. Sh. Inoyatov, O. V. Snurnitsyna, M. V. Lobanov, O. Yu. Malinina, Yu. L. Demidko, M. S. Taratkin, L. M. Rapoport, M. E. Enikeev, P. V. Glybochko
المصدر: Андрология и генитальная хирургия, Vol 21, Iss 2, Pp 20-25 (2020)
مصطلحات موضوعية: postcoital cystitis, urethral transposition, filler, urethral dystopia, hymenoplasty, Surgery, RD1-811, Diseases of the genitourinary system. Urology, RC870-923
وصف الملف: electronic resource
-
9Academic Journal
المؤلفون: О. V. Snurnitsina, M. V. Lobanov, I. Sh. Inoyatov, A. Nikitin, B. A. Slobodyanyuk, L. M. Rapoport, M. E. Enikeev
المصدر: Андрология и генитальная хирургия, Vol 21, Iss 2, Pp 44-50 (2020)
مصطلحات موضوعية: prolapse of the pelvic organs, cystocele, hysteroptosis, transvaginal surgery, mesh implant, Surgery, RD1-811, Diseases of the genitourinary system. Urology, RC870-923
وصف الملف: electronic resource
-
10Academic Journal
المؤلفون: D. V. Enikeev, P. V. Glybochko, Yu. G. Alyaev, L. M. Rapoport, M. E. Enikeev, L. G. Spivak, D. G. Tsarichenko, N. I. Sorokin, R. B. Sukhanov, A. M. Dymov, O. Kh. Khamraev, M. Ya. Gaas, M. S. Taratkin
المصدر: Андрология и генитальная хирургия, Vol 18, Iss 3, Pp 83-88 (2017)
مصطلحات موضوعية: thulep, holep, laser enucleation, monopolar enucleation, removal of prostate adenoma, infravesical obstruction, benign prostatic hyperplasia, Surgery, RD1-811, Diseases of the genitourinary system. Urology, RC870-923
وصف الملف: electronic resource
-
11Academic Journal
المؤلفون: P. V. Glybochko, Yu. G. Alyaev, L. M. Rapoport, M. E. Enikeev, D. V. Enikeev, N. I. Sorokin, R. B. Sukhanov, A. M. Dymov, O. Kh. Khamraev, D. S. Davydov, M. S. Taratkin
المصدر: Андрология и генитальная хирургия, Vol 16, Iss 4, Pp 62-66 (2016)
مصطلحات موضوعية: holmium laser enucleation of the prostate, holmium laser adenomectomy, benign prostatic hyperplasia, bladder outlet obstruction, removal of the adenoma, Surgery, RD1-811, Diseases of the genitourinary system. Urology, RC870-923
وصف الملف: electronic resource
-
12Academic Journal
المؤلفون: D. V. Enikeev, L. M. Rapoport, A. V. Amosov, M. E. Enikeev, D. V. Chinenov, O. V. Snurnitsyna, A. N. Gerasimov, Z. K. Dzhalaev, M. Ya. Gaas, E. A. Laukhtina, M. S. Taratkin, Д. В. Еникеев, Л. М. Рапопорт, А. В. Амосов, М. Э. Еникеев, Д. В. Чиненов, О. В. Снурницына, А. Н. Герасимов, З. К. Джалаев, М. Я. Гаас, Е. А. Лаухтина, М. С. Тараткин
المصدر: Cancer Urology; Том 14, № 3 (2018); 43-50 ; Онкоурология; Том 14, № 3 (2018); 43-50 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2018-14-3
مصطلحات موضوعية: малоинвазивная терапия, cryoablation, brachytherapy, HIFU therapy, complication, ablation, minimally invasive therapy, криоаблация, брахитерапия, HIFU-терапия, осложнение, аблация
وصف الملف: application/pdf
Relation: https://oncourology.abvpress.ru/oncur/article/view/844/784; Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63(1):11–30. DOI:10.3322/caac.21166. PMID: 23335087.; Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2017. CA Cancer J Clin 2017;67(1):7–30. PMID: 28055103. DOI:10.3322/caac.21387.; Bell K.J., Del Mar C., Wright G. et al. Prevalence of incidental prostate cancer: A systematic review of autopsy studies. Int J Cancer 2015;137(7):1749–57. DOI:10.1002/ijc.29538. PMID: 25821151.; Mottet N., Bellmunt J., Bolla M. et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: screening, diagnosis, and local treatment. Eur Urol 2017;71(4):618–29. DOI:10.1016/j.eururo.2016.08.003. PMID: 27568654.; Ficarra V., Novara G., Artibani W. et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol 2009;55(5):1037–63. DOI:10.1016/j.eururo.2009.01.036. PMID: 19185977.; Coelho R.F., Rocco B., Patel M.B. et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a critical review of outcomes reported by high-volume centers. J Endourol 2010;24(12):2003–15. DOI:10.1089/end.2010.0295. PMID: 20942686.; Marien A., Gill I., Ukimura O. et al. Target ablation-image-guided therapy in prostate cancer. Urol Onol 2014;32(6):912–23. DOI:10.1016/j.urolonc.2013.10.014. PMID: 24411788.; Coleman J.A., Scardino P.T. Targeted prostate cancer ablation: energy options. Curr Opin Urol 2013;23(2):123–8. DOI:10.1097/MOU.0b013e32835d9e94. PMID: 23287462.; Rees J., Patel B., MacDonagh R., Persad R. Cryosurgery for prostate cancer. BJU Int 2004;93(6):710–4. DOI:10.1111/j.1464-410X.2003.04746.x. PMID: 15049977.; Han K.R., Belldegrun A.S. Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int 2004;93(1):14–8. PMID: 14678360.; Aus G. Current status of HIFU and cryotherapy in prostate cancer – a review. Eur Urol 2006;50(5):927–34. DOI:10.1016/j.eururo.2006.07.011. PMID: 16971038.; Cordeiro E.R., Cathelineau X., Thüroff S. et al. High-intensity focused ultra-sound (HIFU) for definitive treatment of prostate cancer. BJU Int 2012;110(9):1228–42. DOI:10.1111/j.1464-410X.2012.11262.x. PMID: 22672199.; Clyne M. Prostate cancer: prostatic swelling and shift upon HIFU. Nat Rev Urol 2013;10(6):306. DOI:10.1038/nrurol.2013.98. PMID: 23628808.; Shoji S., Uchida T., Nakamoto M. et al. Prostate swelling and shift during high intensity focused ultrasound: implication for targeted focal therapy. J Urol 2013;190(4):1224–32. DOI:10.1016/j.juro.2013.03.116. PMID: 23583532.; Rebillard X., Soulié M., Chartier-Kastler E. et al. HIFU in prostate cancer; a systematic literature review of the French Association of Urology. BJU Int 2008;101(10):1205–13. DOI:10.1111/j.1464-410X.2008.07504.x. PMID: 18325057.; De Bari B., Daidone A., Alongi F. Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature. Crit Rev Oncol Hematol 2015;94(3):360–70. DOI:10.1016/j.critrevonc.2015.02.003. PMID: 25819287.; National Institute for Health and Care Excellence (NICE). Prostate Cancer: Diagnosis and Treatment. Full Guidance. CG58, 2008.; US Department of Health and Human Services: Agency for Healthcare Research and Quality. Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer. Health Care Bulletin No. 13, 2008.; US Department of Health and Human Services: Agency for Healthcare Research and Quality. Comparative Evaluation of Radiation Treatments for Clinically Localized Prostate Cancer: An Update, 2010.; Pisansky T.M., Hunt D., Gomella L.G. et al. Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910. J Clin Oncol 2015;33(4):332–9. DOI:10.1200/JCO.2014.58.0662. PMID: 25534388.; Hinnen K.A., Battermann J.J., van Roermund J.G. et al. Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2010;76(5):1433–8. DOI:10.1016/j.ijrobp.2009.03.049. PMID: 19540075.; Cornu J.N., Merlet B., Ciofu C. et al. Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial. Eur Urol 2011;59(1):148–54. DOI:10.1016/j.eururo.2010.10.031. PMID: 21030144.; Filocamo M.T., Li Marzi V., Del Popolo G. et al. Pharmacologic treatment in postprostatectomy stress urinary incontinence. Eur Urol 2007;51(6):1559–64. DOI:10.1016/j.eururo.2006.08.005. PMID: 16942833.; Alan C., Eren A.E., Ersay A.R. et al. Efficacy of duloxetine in the early management of urinary continence after radical prostatectomy. Curr Urol 2015;8(1):43–8. DOI:10.1159/000365688. PMID: 26195963.; Geraerts I., Van Poppel H., Devoogdt N. et al. Influence of preoperative and postoperative pelvic floor muscle training (PFMT) compared with postoperative PFMT on urinary incontinence after radical prostatectomy: a randomized controlled trial. Eur Urol 2013;64(5):766–72. DOI:10.1016/j.eururo.2013.01.013. PMID: 23357349.; Campbell S.E., Glazener C.M., Hunter K.F. et al. Conservative management for postprostatectomy urinary incontinence. Cochrane Database Syst Rev 2012;1. DOI:10.1002/14651858.CD001843.pub4. PMID: 22258946.; Schröder A., Abrams P., Andersson K.E. et al. Guidelines on urinary incontinence. In: EAU guidelines. European Association of Urology. Ed. A.G. Arnheim. Arnheim, the Netherlands, 2010. Pp. 11–28.; Imamoglu M.A., Tuygun C., Bakirtas H. et al. The comparison of artificial urinary sphincter implantation and endourethral macroplastique injection for the treatment of postprostatectomy incontinence. Eur Urol 2005;47(2):209–13. DOI:10.1016/j.eururo.2004.08.019. PMID: 15661416.; Secin F.P., Martínez-Salamanca J.I., Eilber K.S. Limited efficacy of permanent injectable agents in the treatment of stress urinary incontinence after radical prostatectomy. Arch Esp Urol 2005;58(5):431–6. PMID: 16078785.; Bauer R.M., Soljanik I., Füllhase C. et al. Results of the Advance transobturator male sling after radical prostatectomy and adjuvant radiotherapy. Urology 2011;77(2):474–9. DOI:10.1016/j.urology.2010.07.541. PMID: 21167563.; Cornu J.N., Sèbe P., Ciofu C. et al. Mid-term evaluation of the transobturator male sling for post-prostatectomy incontinence: focus on prognostic factors. BJU Int 2011;108(2):236–40. DOI:10.1111/j.1464-410X.2010.09765.x. PMID: 20955265.; Silva L.A., Andriolo R.B., Atallah A.N., da Silva E.M. Surgery for stress urinary incontinence due to presumed sphincter deficiency after prostate surgery. Cochrane Database Syst Rev 2011;(4):CD008306. DOI:10.1002/14651858.CD008306.pub2. PMID: 21491408.; Herschorn S., Bruschini H., Comiter C. et al. Surgical treatment of stressincontinence in men. Neurourol Urodyn 2010;29(1):179–90. DOI:10.1002/nau.20844. PMID: 20025026.; Ramsay C.R., Adewuyi T.E., Gray J. et al. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation. Health Technol Assess 2015;19(49):1–490. DOI:10.3310/hta19490. PMID: 26140518.; Ward J.F., Jones J.S. Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry. BJU Int 2012;109(11):1648–54. DOI:10.1111/j.1464-410X.2011.10578.x. PMID: 22035200.; Ohashi T., Yorozu A., Toya K. et al. Predictive factors of acute urinary retention requiring catheterization following 125I prostate brachytherapy. Jpn J Clin Oncol 2006;36(5):285–9. DOI:10.1093/jjco/hyl008. PMID: 16698803.; Bucci J., Morris W.J., Keyes M. et al. Predictive factors of urinary retention following prostate brachytherapy. Int J Radiat Oncol Biol Phys 2002;53(1):91–8. PMID: 12007946.; Pellizzon A.C., Salvajoli J.V., Maia M.A. et al. Late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer. J Urol 2004;171(3):1105–8. DOI:10.1097/01.ju.0000113260.07979.d3. PMID: 14767280.; Henderson A., Ismail A.K., Cunningham M. et al. Toxicity and early biochemical outcomes from 125iodine prostate brachytherapy in the UK. A prospective study. Clin Oncol (R Coll Radiol) 2004;16(2):95–104. PMID: 15074730.; Martens C., Pond G., Webster D. et al. Relationship of the international prostate symptom score with urinary flow studies, and catheterization rates following 125I prostate brachytherapy. Brachytherapy 2006;5(1):9–13. DOI:10.1016/j.brachy.2005.12.002. PMID: 16563992.; Allardice J.T., Standfield N.J., Wyatt A.P. Acute urinary retention: which catheter? Ann R Coll Surg Engl 1988;70(6):366–8. PMID: 3207328.; Fitzpatrick J.M., Desgrandchamps F., Adjali K. et al. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia. BJU Int 2012;109(1):88–95. DOI:10.1111/j.1464-410X.2011.10430.x. PMID: 22117624.; Ahyai S.A., Gilling P., Kaplan S.A. et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 2010;58(3):384–97. DOI:10.1016/j.eururo.2010.06.005. PMID: 20825758.; Chi A.C., Han J., Gonzalez C.M. Urethral strictures and the cancer survivor Curr Opin Urol 2014;24(4):415–20. DOI:10.1097/MOU.0000000000000070. PMID: 24809412.; Rourke K., Kinnaird A., Zorn J. Observations and outcomes of urethroplasty for bulbomembranous stenosis after radiation therapy for prostate cancer. World J Urol 2016;34(3):377–82. DOI:10.1007/s00345-015-1608-2. PMID: 26047655.; Elliott S.P., Meng M.V., Elkin E.P. et al. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE. J Urol 2007;178(2):529–34. DOI:10.1016/j.juro.2007.03.126. PMID: 17570425.; Borboroglu P.G., Sands J.P., Roberts J.L et al. Risk factors for vesicourethral anastomotic stricture after radical prostatectomy. Urology 2000;56(1):96–100. PMID: 10869633.; Sandhu J.S., Gotto G.T., Herran L.A. et al. Age, obesity, medical comorbidities and surgical technique are predictive of symptomatic anastomotic strictures after contemporary radical prostatectomy. J Urol 2011;185(6):2148–52. DOI:10.1016/j.juro.2011.02.003. PMID: 21496848.; Mundy A.R., Andrich D.E. Posterior urethral complications of the treatment of prostate cancer. BJU Int 2012;110(3):304–25. DOI:10.1111/j.1464-410X.2011.10864.x. PMID: 22340079.; Bryk D.J., Yamaguchi Y., Zhao L.C. Tissue transfer techniques in reconstructive urology. Korean J Urol 2015;56(7):478–86. DOI:10.4111/kju.2015.56.7.478. PMID: 26175866.; Meeks J.J., Erickson B.A., Granieri M.A. et al. Stricture recurrence after urethroplasty: a systematic review. J Urol 2009;182(4):1266–70. DOI:10.1016/j.juro.2009.06.027. PMID: 19683309.; Herschorn S., Elliott S.P., Coburn M. et al. SIU/ICUD consultation on urethral strictures: posterior urethral stenosis after treatment of prostate cancer, Urology 2014;83(3 Suppl):S59–70. DOI:10.1016/j.urology.2013.08.036. PMID: 24361008.; Sanda M.G., Dunn R.L., Michalski J. et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008;358(12):1250–61. DOI:10.1056/NEJMoa074311. PMID: 18354103.; Ficarra V., Novara G., Ahlering T.E. et al. Systematic review and meta-analysis of studies reporting potency rates after robotassisted radical prostatectomy. Eur Urol 2012;62(3):418–30. DOI:10.1016/j.eururo.2012.05.046. PMID: 22749850.; Incrocci L., Jensen P.T. Pelvic radiotherapy and sexual function in men and women. J Sex Med 2013;10(Suppl 1):53–64. DOI:10.1111/jsm.12010. PMID: 23387912.; Ellis D.S., Manny J., Rewcastle J.C. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. Urology 2007;70(6 Suppl):9–15. DOI:10.1016/j.urology.2007.07.036. PMID: 18194712.; Poissonnier L., Chapelon J.Y., Rouvière O. et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 2007;51(2):381–7. DOI:10.1016/j.eururo.2006.04.012. PMID: 16857310.; Merrick G.S., Wallner K.E., Butler W.M. Prostate cryotherapy: more questions than answers. Urology 2005;66(1):9–15. DOI:10.1016/j.urology.2004.12.039. PMID: 15992870.; Nehra A., Jackson G., Miner M. et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc 2012;87(8):766–78. DOI:10.1016/j.mayocp.2012.06.015. PMID: 22862865.; Swearingen D., Nehra A., Morelos S., Peterson C.A. Hemodynamic effect of avanafil and glyceryl trinitrate coadministration. Drugs Context 2013;2013:212–48. DOI:10.7573/dic.212248. PMID: 24432037.; Yu Y.F., Nichol M.B., Yu A.P., Ahn J. Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program. Value Health 2005;8(4):495–505. DOI:10.1111/j.1524-4733.2005.00041.x. PMID: 16091027.; Kalder M., Pantazis K., Dinas K. et al. Discontinuation of treatment using anticholinergic medications in patients with urinary incontinence. Obstet Gynecol 2014;124(4):794–800. DOI:10.1097/AOG.0000000000000468. PMID: 25198276.; Coombs P.G., Heck M., Guhring P. et al. A review of outcomes of an intracavernosal injection therapy programme. BJU Int 2012;110(11):1787–91. DOI:10.1111/j.1464-410X.2012.11080.x. PMID: 22564343.; Porst H., Burnett A., Brock G. et al. SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med 2013;10(1):130–71. DOI:10.1111/jsm.12023. PMID: 23343170.; Antonini G., Busetto G.M., De Berardinis E. et al. Minimally invasive infrapubic inflatable penile prosthesis implant for erectile dysfunction: Evaluation of efficacy, satisfaction profile and complications. Int J Impot Res 2016;28(1):4–8. DOI:10.1038/ijir.2015.33. PMID: 26657316.; Elliott S.P., McAninch J.W., Chi T. et al. Management of severe urethral complications of prostate cancer therapy. J Urol 2006;176(6 Pt 1):2508–13. DOI:10.1016/j.juro.2006.07.152. PMID: 17085144.; Walsh P.C., Partin A.W. Anatomic radical retropubic prostatectomy. In: Campbell-Walsh Urology. Saunders Elsevier, Philadelphia, Pa, USA, 9th edn, 2006.; Noldus J., Fernandez S., Huland H. Rectourinary fistula repair using the Latzko technique. J Urol 1999;161(5):1518–20. PMID: 10210386.; Bahn D.K., Lee F., Badalament R. et al.Targeted cryoablation of the prostate: 7-year outcomes in the primary treat ment of prostate cancer. Urology 2002;60(2 Suppl 1):3–11. PMID: 12206842.; Mack D., Jungwirth A., Adam U. et al. Long-term follow-up after open perineal cryotherapy in patients with locally confined prostate cancer. Eur Urol 1997;32(2):129–32. PMID: 9286641.; Thomas C., Jones J., Jager W. et al. Incidence, clinical symptoms and management of rectourethral fistulas after radical prostatectomy. J Urol 2010;183(2):608– 12. DOI:10.1016/j.juro.2009.10.020. PMID: 20018317.; dal Moro F., Mancini M., Pinto F. et al. Successful repair of latrogenic rectourinary fistulas using the posterior sagittal transrectal approach: 15-year experience. World J Surg 2006;30(1):107–13.; Renschler T.D., Middleton R.G. 30 years of experience with York-Mason repair of recto-urinary fistulas. J Urol 2003; 170(4 Pt 1):1222–5. DOI:10.1097/01.ju.0000082013.58783.17. PMID: 14501729.; https://oncourology.abvpress.ru/oncur/article/view/844
-
13Academic Journal
المؤلفون: P. V. Glybochko, Yu. G. Alyaev, L. M. Rapoport, A. V. Amosov, D. V. Enikeev, M. E. Enikeev, D. V. Chinenov, D. G. Tsarichenko, Z. K. Dzhalaev, Ya. N. Chernov, Zh. Sh. Inoyatov, M. S. Taratkin
المصدر: Onkourologiâ, Vol 14, Iss 2, Pp 27-32 (2018)
مصطلحات موضوعية: cryoablation, renal cancer, percutaneous cryoablation, cryoablation of renal cancer, cryodestruction, Medicine
Relation: https://oncourology.abvpress.ru/oncur/article/view/781; https://doaj.org/toc/1726-9776; https://doaj.org/toc/1996-1812; https://doaj.org/article/3b8032af9af84c15b3b9cea87d52867a
-
14Academic Journal
المؤلفون: A. Z. Vinarov, L. M. Rapoport, G. E. Krupinov, Yu. L. Demidko, D. G. Tsarichenko, E. A. Bezrukov, M. E. Enikeev, V. A. Tereshchenko
المصدر: Onkourologiâ, Vol 14, Iss 2, Pp 102-108 (2018)
مصطلحات موضوعية: laparoscopic robot-assisted radical prostatectomy, biofeedback, Medicine
Relation: https://oncourology.abvpress.ru/oncur/article/view/808; https://doaj.org/toc/1726-9776; https://doaj.org/toc/1996-1812; https://doaj.org/article/e1403445603c470ebf3fb7d841eae8f7
-
15
المؤلفون: L M, Rapoport, M A, Gazimiev, D O, Korolev, D G, Tsarichenko, Y U A, Svetikova, M E, Enikeev, G N, Akopyan, D V, Chinenov, M S, Taratkin, D V, Enikeev
المصدر: Urologiia (Moscow, Russia : 1999). (6)
مصطلحات موضوعية: Kidney Calculi, Treatment Outcome, Lithotripsy, Thulium, Ureteroscopy, Humans, Lithotripsy, Laser, Retrospective Studies, Russia
-
16
المؤلفون: E. E. Laukhtina, G.B. Altschuler, A. V. Kurkov, V. A. Andreeva, I. V. Yaroslavsky, V. A. Arkhipova, M. E. Enikeev
المصدر: 2020 International Conference Laser Optics (ICLO).
مصطلحات موضوعية: Laparoscopic surgery, Blue laser, Materials science, medicine.medical_treatment, Laser, Nephrectomy, 030218 nuclear medicine & medical imaging, law.invention, Resection, 03 medical and health sciences, 0302 clinical medicine, law, 030220 oncology & carcinogenesis, Fiber laser, Hemostasis, medicine, Diode, Biomedical engineering
-
17
المؤلفون: D. V. Enikeev, L. M. Rapoport, A. V. Amosov, M. E. Enikeev, D. V. Chinenov, O. V. Snurnitsyna, A. N. Gerasimov, Z. K. Dzhalaev, M. Ya. Gaas, E. A. Laukhtina, M. S. Taratkin
المصدر: Onkourologiâ, Vol 14, Iss 3, Pp 43-50 (2018)
مصطلحات موضوعية: medicine.medical_specialty, Urology, medicine.medical_treatment, Brachytherapy, brachytherapy, complication, ablation, Prostate cancer, Medicine, Radiology, Nuclear Medicine and imaging, minimally invasive therapy, business.industry, Prostatectomy, Open surgery, Cancer, Cryoablation, hifu therapy, medicine.disease, prostate cancer, High-intensity focused ultrasound, Oncology, Nephrology, cryoablation, Surgery, Radiology, business, Complication
-
18
المؤلفون: L V, Tsoy, D O, Korolev, A Z, Vinarov, M E, Enikeev, Yu V, Lerner, D G, Tsarichenko, N A, Popov, A F, Abdusalamov, Yu P, Gorobets, Yu L, Demidko, V A, Varshavskiy, A A, Zamyatnin, L M, Rapoport
المصدر: Urologiia (Moscow, Russia : 1999). (6)
مصطلحات موضوعية: Arrestins, Biomarkers, Tumor, Recoverin, Humans, Carcinoma, Renal Cell, Kidney Neoplasms
-
19
المؤلفون: L S, Demidko, V I, Rudenko, V V, Fadeev, Yu L, Demidko, A V, Amosov, G M, Kuzmicheva, V A, Grigoryan, M E, Enikeev, M V, Amosova
المصدر: Urologiia (Moscow, Russia : 1999). (4)
مصطلحات موضوعية: Recurrence, Humans, Osteoporosis, Calcium, Urinary Calculi, Uric Acid
-
20
المؤلفون: Yu L, Demidko, V I, Rudenko, V A, Grigoryan, M E, Enikeev, S N, Allenov, I G, Kasiteridi, T A, Ujegov, A V, Amosov
المصدر: Urologiia (Moscow, Russia : 1999). (2)
مصطلحات موضوعية: Plant Extracts, Lithotripsy, Secondary Prevention, Ureteroscopy, Humans, Calcium, Urinary Calculi, Nephrolithotomy, Percutaneous, Diuresis, Phytotherapy